Search results
CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development...
Digital Journal· 7 days ago(Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), today announced ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 4 days agoCanadian Solar Releases 2023 Corporate Sustainability Report PR Newswire GUELPH, ON, May 31, 2024 GUELPH, ON, May 31, 2024 /PRNewswire/ -- Canadian Solar Inc. (the "Company", or "Canadian Solar ...